Purpose: The physical compatibility of cisatracurium with selected drugs during simulated Y-site administration was studied.
Methods: Study drugs were selected based on the lack of physical compatibility data with cisatracurium and their use in intensive care units. Test admixtures were prepared by mixing 2.